Scientia Advisors - Science, knowledge and skill for your competitive advantage

Video of Harry Glorikian's interview at BioPharm America 2011

LinkedIn Facebook Twitter Delicious

Scientia Advisors in the News

Stock News Now Wire interviews Harry Glorikian on personalized medicine and the impact of sequencing on clinical decisions and therapeutics choices

September 7, 2011

SNN wired interviewed Harry Glorikian at BioPharm America 2011 on personalized medicine and the impact of sequencing on clinical decisions and therapeutics choices. View the video on SNN Wire's website.

SCIENTIA ADVISORS, LLC  |  info@scientiaadv.com


55 Cambridge Parkway, Suite 300E, Cambridge MA 02142  |  Phone: 617-299-3000  |  Fax: 617-812-0315

© 2012 Scientia Advisors LLC